10a. The Benefits of Aggressive Blood Pressure Control in the
Multiple Risk Patient

Sunday, September 17, 2000
12:30 - 14:00

11:45-12:30 Refreshments (Ballroom C)
12:30-12:35 Introduction
H-H. Parving, Denmark
12:35-12:50 The burden of macrovascular disease in diabetes
G. Steiner, Canada
12:50-12:55 Q and A session
12:55-13:10 Factors influencing long-term prognosis of diabetes
H-H Parving, Denmark
13:10-13:15 Q and A session
13:15-13:30 Managing the global burden of CAD in the multiple risk patient
T. Morgan, Australia
13:30-13:35 Q and A session
13:35-13:50 Current and future possibilities for the prevention of atherosclerotic disease in type 2 diabetes
D.J. Betteridge, UK
13:50-13:55 Q and A session
13:55-14:00 Summary and conclusions
14:00 Close

 
Renaissance Hotel


Trefor Morgan, Australia
Hans-Henrik Parving, Denmark

Pfizer Inc.

FOR GENERAL ENQUIRIES
Sharon Rayner, PPSI,
Wicker House, High Street, Worthing,
West Sussex, BN11 1DJ, UK
Tel: +44 1903 288234,
Fax: + 44 1903 282707
E-mail: srayner@hbase.com
FOR REGISTRATION ENQUIRIES
Helen Capelin, PPSI
3 Liverpool Gardens, Worthing,
West Sussex, BN11 1TF, UK
Tel: +44 1903 703044
Fax: +44 1903 703001
E-mail: hcapelin@hbase.com

FOR ABSTRACT ENQUIRIES
Charlie Bellinger, PPSI,
Wicker House, High Street, Worthing,
West Sussex, BN11 1DJ, UK
Tel: +44 1903 288203
Fax: + 44 1903 282707
E-mail: cbellinger@hbase.com